Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...

What I love most about these masks, though is that they helped to clear my perioral dermatitis. I'm sure they were a key part ...

Researchers compare two broiler breeds with different growth rates (fast-growing vs slow-growing) raised in an indoor ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

The webcast for this conference may be accessed at the "Events” section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference ...

In addition to medication, you can use topical treatments — in gel, patch or cream form, as a healing solution for cold sores. Shop the best ones, as recommended by dermatologists.